Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sclerostin: a gem from the genome leads to bone-building antibodies.

× No keyword cloud information.

45 in total

1. Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.

Authors: Maria-Grazia Ascenzi; Vivian P Liao; Brittany M Lee; Fabrizio Billi; Hua Zhou; Robert Lindsay; Felicia Cosman; Jeri Nieves; John P Bilezikian; David W Dempster
Journal: J Bone Miner Res Date: 2012-03 Impact factor: 6.741

2. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.

Authors: Xiaolin Tu; Yumie Rhee; Keith W Condon; Nicoletta Bivi; Matthew R Allen; Denise Dwyer; Marina Stolina; Charles H Turner; Alexander G Robling; Lilian I Plotkin; Teresita Bellido
Journal: Bone Date: 2011-10-30 Impact factor: 4.398

3. Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.

Authors: Gill Holdsworth; Patrick Slocombe; Carl Doyle; Bernadette Sweeney; Vaclav Veverka; Kelly Le Riche; Richard J Franklin; Joanne Compson; Daniel Brookings; James Turner; Jeffery Kennedy; Rachael Garlish; Jiye Shi; Laura Newnham; David McMillan; Mariusz Muzylak; Mark D Carr; Alistair J Henry; Thomas Ceska; Martyn K Robinson
Journal: J Biol Chem Date: 2012-06-13 Impact factor: 5.157

4. The myokine irisin increases cortical bone mass.

Authors: Graziana Colaianni; Concetta Cuscito; Teresa Mongelli; Paolo Pignataro; Cinzia Buccoliero; Peng Liu; Ping Lu; Loris Sartini; Mariasevera Di Comite; Giorgio Mori; Adriana Di Benedetto; Giacomina Brunetti; Tony Yuen; Li Sun; Janne E Reseland; Silvia Colucci; Maria I New; Mone Zaidi; Saverio Cinti; Maria Grano
Journal: Proc Natl Acad Sci U S A Date: 2015-09-15 Impact factor: 11.205

10. Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.

Authors: Feng Li; Jarret D Cain; Joyce Tombran-Tink; Christopher Niyibizi
Journal: Biochim Biophys Acta Mol Basis Dis Date: 2018-08-01 Impact factor: 5.187

Sclerostin: a gem from the genome leads to bone-building antibodies.

1. Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.

2. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.

3. Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.

4. The myokine irisin increases cortical bone mass.

Review 5. Role of Irisin on the bone-muscle functional unit.

6. Pten deletion in Dmp1-expressing cells does not rescue the osteopenic effects of Wnt/β-catenin suppression.

7. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.

Review 8. WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Review 9. Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

10. Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.